| 15.66 0.08 (0.51%) | 04-27 11:32 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 19.31 | 1-year : | 22.56 |
| Resists | First : | 16.54 | Second : | 19.31 |
| Pivot price | 15.65 |
|||
| Supports | First : | 14.4 | Second : | 13.09 |
| MAs | MA(5) : | 15.63  |
MA(20) : | 15.35 |
| MA(100) : | 16.5 |
MA(250) : | 15.08 |
|
| MACD | MACD : | 0.2 |
Signal : | 0.2 |
| %K %D | K(14,3) : | 50.4 |
D(3) : | 53.5 |
| RSI | RSI(14): 55 |
|||
| 52-week | High : | 19.85 | Low : | 10.68 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.[ SHC ] has closed below upper band by 48.6%. Bollinger Bands are 25.5% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 15.65 - 15.75 | 15.75 - 15.84 |
| Low: | 14.96 - 15.1 | 15.1 - 15.22 |
| Close: | 15.37 - 15.58 | 15.58 - 15.77 |
Sotera Health Company provides sterilization, and lab testing and advisory services in the United States, Canada, Europe, and internationally. The company's sterilization services include gamma and electron beam irradiation, and EO processing; Nelson Labs comprise microbiological and analytical chemistry testing; and advisory services for medical device and biopharmaceutical industries. It serves medical devices; pharmaceuticals; food and agricultural products; and commercial, advanced, and specialty application industries. The company was formerly known as Sotera Health Topco, Inc. and changed its name to Sotera Health Company in October 2020. Sotera Health Company was incorporated in 2017 and is headquartered in Broadview Heights, Ohio.
Mon, 27 Apr 2026
SHC Price Today: Sotera Health Company Stock Price, Quote & Chart | MEXC - MEXC Exchange
Sun, 26 Apr 2026
All you need to know about Sotera Health (SHC) rating upgrade to buy - MSN
Fri, 24 Apr 2026
Insiders At Sotera Health Sold US$14m In Stock, Alluding To Potential Weakness - 富途牛牛
Fri, 24 Apr 2026
3 Healthcare Stocks That Fall Short - StockStory
Wed, 22 Apr 2026
Sotera Health (SHC) Q3 2024 Earnings Transcript - The Motley Fool
Tue, 21 Apr 2026
Sotera Health Company to Release First-Quarter Financial Results on May 5, 2026 - Quiver Quantitative
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Diagnostics & Research
|
|
| Shares Out | 285 (M) |
| Shares Float | 192 (M) |
| Held by Insiders | 2.3 (%) |
| Held by Institutions | 85.8 (%) |
| Shares Short | 12,100 (K) |
| Shares Short P.Month | 8,830 (K) |
| EPS | 0.27 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 2.13 |
| Profit Margin | 6.6 % |
| Operating Margin | 35.7 % |
| Return on Assets (ttm) | 8.1 % |
| Return on Equity (ttm) | 15.4 % |
| Qtrly Rev. Growth | 4.5 % |
| Gross Profit (p.s.) | 2.26 |
| Sales Per Share | 4.06 |
| EBITDA (p.s.) | 1.94 |
| Qtrly Earnings Growth | 175.3 % |
| Operating Cash Flow | 287 (M) |
| Levered Free Cash Flow | 237 (M) |
| PE Ratio | 58.05 |
| PEG Ratio | 1.3 |
| Price to Book value | 7.35 |
| Price to Sales | 3.85 |
| Price to Cash Flow | 15.56 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|